AstraZeneca PLC (AZN)
192.13
+2.23
(+1.17%)
USD |
NYSE |
Mar 16, 16:00
192.13
0.00 (0.00%)
After-Hours: 20:00
AstraZeneca Market Cap : 297.86B for March 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| GSK Plc | 107.73B |
| Mereo BioPharma Group Plc | 63.90M |
| Regeneron Pharmaceuticals, Inc. | 79.99B |
| Biodexa Pharmaceuticals Plc | 0.6690M |
| Moderna, Inc. | 21.06B |
Market Cap Related Metrics
| PE Ratio | 58.60 |
| PS Ratio | 10.20 |
| PEG Ratio | 1.280 |
| Price to Book Value | 6.120 |
| Price to Free Cash Flow | 66.82 |
| Price | 192.13 |
| Earnings Yield | 1.71% |
| PEGY Ratio | 1.235 |
| Operating PE Ratio | 44.04 |
| Normalized PE Ratio | 57.67 |